Data gathered: September 22
Alternative Data for Akero Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 23 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,290 | Sign up | Sign up | Sign up |
| Twitter Followers | 456 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 68 | Sign up | Sign up | Sign up |
About Akero Therapeutics
Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States.
| AI Score | / 100 |
| Price | $46.41 |
| Industry | Biotechnology |
In the news
 |
NTLA Completes Enrollment in Pivotal Study on HAE Candidate, Stock UpSeptember 19 - Yahoo |
 |
Roche's 89bio Buyout: Building A Combo-Ready Metabolic Franchise Beyond GLP-1 WarsSeptember 18 - SeekingAlpha |
 |
89bio: Pegozafermin MASH Drug Advancement Nets Roche AcquisitionSeptember 18 - SeekingAlpha |
Insider Transactions View All
| Rolph Timothy filed to sell 166,571 shares at $43. September 12 '25 |
| White William Richard filed to sell 57,752 shares at $43. September 12 '25 |
| Yale Catriona filed to sell 90,829 shares at $43. September 12 '25 |
| Young Jonathan filed to sell 196,898 shares at $43. September 12 '25 |
| Cheng Andrew filed to sell 473,902 shares at $43. September 12 '25 |
Similar companies
Read more about Akero Therapeutics (AKRO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Akero Therapeutics?
The Market Cap of Akero Therapeutics is $3.62B.
What is the current stock price of Akero Therapeutics?
Currently, the price of one share of Akero Therapeutics stock is $46.41.
How can I analyze the AKRO stock price chart for investment decisions?
The AKRO stock price chart above provides a comprehensive visual representation of Akero Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Akero Therapeutics shares. Our platform offers an up-to-date AKRO stock price chart, along with technical data analysis and alternative data insights.
Does AKRO offer dividends to its shareholders?
As of our latest update, Akero Therapeutics (AKRO) does not offer dividends to its shareholders. Investors interested in Akero Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Akero Therapeutics?
Some of the similar stocks of Akero Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.